| Similarity | Rank | |
|---|---|---|
| high-throughput | 0.769 | 76824 |
| cost-effectiveness | 0.734 | 43293 |
| commercialization | 0.727 | 26074 |
| capacity-building | 0.716 | 71932 |
| technology-based | 0.715 | 59708 |
| implementation | 0.715 | 2825 |
| pre-clinical | 0.715 | 79324 |
| efficiencies | 0.700 | 16247 |
| replicable | 0.699 | 79173 |
| preclinical | 0.696 | 49806 |
| feasibility | 0.696 | 16045 |
| cost-effectively | 0.695 | 51674 |
| time-to-market | 0.693 | 82660 |
| commercialisation | 0.690 | 54888 |
| re-engineering | 0.688 | 70872 |
| scalable | 0.684 | 17522 |
| proof-of-concept | 0.683 | 74320 |
| genotyping | 0.681 | 97100 |
| proteomics | 0.680 | 80676 |
| reengineering | 0.679 | 91185 |
| interventions | 0.671 | 8892 |
| life-cycle | 0.670 | 47134 |
| large-scale | 0.670 | 10507 |
| technologies | 0.670 | 2313 |
| ramp-up | 0.668 | 92670 |